Pharma Market in Asia Pacific to Post Double Digit Growth
The Asia-Pacific pharma market is forecasted to grow at a CAGR of over 12% during 2010-2012, says a new research study by RNCOS.
Noida, India, October 21, 2009 --(PR.com)-- The influence of Asia-Pacific region on the global pharma market has significantly risen over the last few years. The region is getting benefit from its large population base and low manufacturing cost factor. As per a new research study “Asia Pacific Pharma Sector Analysis” by RNCOS, it is forecasted that Asia-Pacific pharma market will grow at a CAGR of over 12% during 2010-2012.
They have done an extensive research on the pharma market in Asia-Pacific to analyze various trends undergoing in key pharma markets. They believe that generics will be the main growth driver of drugs sales in the region and their report provides a detailed analysis of both generics and branded drugs markets at country level. The report also studies various micro and macroeconomic factors associated with the industry and analyzes their importance in driving growth of the industry in future.
As regulatory environment plays an important role in the growth of any pharmaceutical market, their research includes a detailed overview of regulatory system in different countries of the Asia-Pacific region. This information will help clients in understanding the market in a better way before entering.
Besides, their research study finds that there are various emerging market trends like contract manufacturing, generics that are streamlining themselves in line with the growth of pharmaceutical market in the region. Each of this market trends have been extensively covered in our report. They have found some restraints, which are suppressing growth of the pharma market. In this regard, their report gives certain useful recommendations, which will be proven beneficial to client.
“Asia Pacific Pharma Sector Analysis” comprises of an extensive and objective analysis of pharma market in the Asia-Pacific region. It features an analysis of future direction, supplemented with facts and figures. Thus, the report serves as a useful guide for pharma companies, consultants and investors who are planning to enter the Asia-Pacific pharma market.
For Free Sample of this report visit: http://www.rncos.com/Report/IM226.htm
Check Discounted Reports on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
###
They have done an extensive research on the pharma market in Asia-Pacific to analyze various trends undergoing in key pharma markets. They believe that generics will be the main growth driver of drugs sales in the region and their report provides a detailed analysis of both generics and branded drugs markets at country level. The report also studies various micro and macroeconomic factors associated with the industry and analyzes their importance in driving growth of the industry in future.
As regulatory environment plays an important role in the growth of any pharmaceutical market, their research includes a detailed overview of regulatory system in different countries of the Asia-Pacific region. This information will help clients in understanding the market in a better way before entering.
Besides, their research study finds that there are various emerging market trends like contract manufacturing, generics that are streamlining themselves in line with the growth of pharmaceutical market in the region. Each of this market trends have been extensively covered in our report. They have found some restraints, which are suppressing growth of the pharma market. In this regard, their report gives certain useful recommendations, which will be proven beneficial to client.
“Asia Pacific Pharma Sector Analysis” comprises of an extensive and objective analysis of pharma market in the Asia-Pacific region. It features an analysis of future direction, supplemented with facts and figures. Thus, the report serves as a useful guide for pharma companies, consultants and investors who are planning to enter the Asia-Pacific pharma market.
For Free Sample of this report visit: http://www.rncos.com/Report/IM226.htm
Check Discounted Reports on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
###
Contact
RNCOS
Shushmul Maheshwari
91-120-4224-700
www.rncos.com
Chief Executive
B-129, Sector 6 Noida - 201301
91-120-4224-707
Shushmul Maheshwari
91-120-4224-700
www.rncos.com
Chief Executive
B-129, Sector 6 Noida - 201301
91-120-4224-707
Contact
Categories